Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus (French, HTML)
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus: French HTML file. From Health Canada, updated May 2024. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2024-05-10
Health Canada carried out a safety review to assess the risk of birth defects with the use of ondansetron, as part of routine health product monitoring and because this drug is not authorized for sale in Canada to treat nausea and vomiting during pregnancy. The use of ondansetron during pregnancy is not recommended because its safety has not been established in pregnant women.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file